Advertisement

Journal of Community Health

, Volume 44, Issue 3, pp 428–435 | Cite as

Human Papillomavirus Vaccination in Georgia: Evaluating the Georgia HPV Work Group

  • Adrian R. King
  • Tamira Moon
  • Gena Agnew
  • Robert A. BednarczykEmail author
Original Paper
  • 72 Downloads

Abstract

HPV-related cancers can be prevented through HPV vaccination, however uptake and completion of the vaccination in the state of Georgia remains suboptimal. The research team conducted two online focus groups with members of the Georgia Cancer Control Consortium HPV Work Group in efforts to better understand the role that the working group could have on increasing vaccination uptake and completion in the state of Georgia. Analysis of the focus groups was completed using a Grounded Theory approach. Various aspects of the Working Group were discussed throughout the focus groups with a number of key points for growth identified both by the participants during the discussion, and by the research team during analysis. Predominantly, a primary point for growth of the Working Group lies in building its capacity to collectively conduct HPV vaccination-related activities. An online webportal specifically designed for the Working Group was identified as a tool for improving Working Group communication, sharing best practices and resources, and to collectively develop activities, research projects, and HPV vaccine promotion events in a culturally competent and age appropriate manner in efforts to improve vaccine uptake and completion throughout the state of Georgia.

Keywords

HPV Human Papillomavirus Vaccination Work Group Coalition strengthening 

Notes

Acknowledgements

This research was funded by the National Cancer Institute (NCI) P-30 Supplement funding program under Award Number P30CA138292. The authors express our sincere gratitude to the members of the Georgia GC3 HPV Work Group for their participation in this research. Research reported in this publication was supported in part by the Intervention Development, Dissemination and Implementation Developing Shared Resource of Winship Cancer Institute of Emory University and NIH/NCI under Award Number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Compliance with Ethical Standards

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical Approval

The project supporting this research was reviewed and approved by the Emory University Institutional Review Board.

Human Rights and Informed Consent

This research report presents information collected during IRB approved focus groups conducted with participants in the State of Georgia. All participants were provided informed consent forms to review before consenting for participation. All participants signed informed consent forms providing their consent to be involved in the research.

References

  1. 1.
    Dunne, E. F., Markowitz, L. E., Chesson, H., Curtis, C. R., Saraiya, M., Gee, J., & Unger, E. R. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR), 60(50), 1705–1708.Google Scholar
  2. 2.
    Friedman, L. S., Kahn, J., Middleman, A. B., Rosenthal, S. L., & Zimet, G. D. (2006). Human Papillomavirus (HPV) vaccine: A position statement of the society for adolescent medicine. Journal of Adolescent Health, 39, 620CrossRefGoogle Scholar
  3. 3.
    Viens, L. J., Henley, J., Watson, M., Markowitz, L. E., Thomas, C. C., Thompson, T. D., Saraiya, M. (2016, August 24, 2017). Human Papillomavirus-associated cancers—United States, 2008–2012. Morbility and Mortality Weekly Report (MMWR). Retrieved from https://www.cdc.gov/mmwr/volumes/65/wr/mm6526a1.htm.
  4. 4.
    Butterfoss, F. W., Morrow, J. D., Rosenthal, A. L. (1998). Immunization coalitions that work: Training for public health professionals. Journal of Public Health Management and Practices, 4(6), 79–87.CrossRefGoogle Scholar
  5. 5.
    Georgia Cancer Control Consortium. (2014). Georgia Cancer Plan 2014–2019.Google Scholar
  6. 6.
    National, H. P. V. Vaccination Roundtable. (2017). Report from Iowa HPV Working Group Listening Session: May 16, 2017. State Coalitions & Roundtables Task Group.Google Scholar
  7. 7.
    Saslow, D. S., Nkonga, J., Brewer, J. L. Z. & Noel, T. (2018). Creating a national coalition to increase human papillomavirus vaccination coverage. Academic Pediatrics, 18, S11–S13.CrossRefGoogle Scholar
  8. 8.
    Georgia Department of Public Health. (2017). Human Papillomavirus Vaccine (HPV) Update.Google Scholar
  9. 9.
    Susan Jolley Awareness Program hosts Cervical Cancer Awareness Day at the Capitol on Jan. 17. (2017). Marietta Daily Journal. Retrieved from https://www.mdjonline.com/news/lifestyle/susan-jolley-awareness-program-hosts-cervical-cancer-awareness-day-at/article_367dfc98-ece5-11e7-8c32-7f27319d1de6.html.
  10. 10.
    Northside Hospital Cancer Institute (Producer). (2017, October 5, 2018). HPV and cervical cancer awareness: A film and expert panel discussion. [Informational Flyer].Google Scholar
  11. 11.
    Northside Hospital Cancer Institute (Producer). (2017, October 5, 2018). HPV Vaccine is Cancer Prevention. [Informational Flyer].Google Scholar
  12. 12.
    Hennink, M. H., Bailey Ajay, I. (2011). Qualitative research methods. London: Sage Publications.Google Scholar
  13. 13.
    HPV | For Clinicians | Tips and time-savers for talking with parents about HPV | Centers for Disease Control and Prevention. (2016, December 29). Retrieved December 10, 2018 from https://www.cdc.gov/hpv/hcp/for-hcp-tipsheet-hpv.html.
  14. 14.
    Borg, L. (2015, July 28, 2015). Rhode Island to mandate HPV vaccine for all 7th graders. Providence Journal. Retrieved from http://www.providencejournal.com/article/20150728/NEWS/150729287.
  15. 15.
    National Conference of State Legislatures. (2018). HPV Vaccine: State Legislation and Statutes. Retrieved from http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx.
  16. 16.
  17. 17.
    Government of the District of Columbia Department of Health. (2018, January 18, 2018). District of Columbia Immunization Requirements School Year 2018–2019. Retrieved from https://dcps.dc.gov/sites/default/files/dc/sites/dcps/publication/attachments/Combined%20Medical%20Forms%20SY%2018-19.pdf.
  18. 18.
    Shots, N. No School. (2018). In G. o. t. D. o. C. D. o. Health (Ed.).Google Scholar
  19. 19.
    School Requirements: School and Day Care Minimum Immunization Requirements. (2018). Retrieved from http://www.vdh.virginia.gov/immunization/requirements/.
  20. 20.
    Mickan, S., & Rodger, S. (2000). Characteristics of effective teams: A literature review. Australian Health Review, 23(3), 201–208.CrossRefGoogle Scholar
  21. 21.
    Mickan, S. M., & Rodger, S. A. (2009). Effective Health Care Teams: A model of six characteristics developed from shared perceptions. Journal of Interprofessional Care, 19(5), 358–370.Google Scholar
  22. 22.
    Pentland, A. S. (2012). The New Science of Building Great Teams. Retrieved from https://hbr.org/2012/04/the-new-science-of-building-great-teams.
  23. 23.
    Georgia Population 2018. (2018, September 17, 2018). Georgia PopulationGoogle Scholar
  24. 24.
    Kegler, M. C., Steckler, A., Mcleroy, K., & Malek, S. H. (1998). Factors that contribute to effective community health promotion coalitions: A study of 10 project ASSIST coalitions in North Carolina. SAGE Journals, 25(3), 338–353.Google Scholar
  25. 25.
    Morrow, H., Collins, B., & Smith, D. (2007). Public health coalitions: Patterns and perceptions in state immunization programs. Journal of Health and Human Services Administration, 30(2), 156–175.Google Scholar
  26. 26.
    The Immunization Partnership. (2017). A Dose of Change: Building Capacity in Your Immunization Coalition. Retrieved from https://www.immunizeusa.org/media/277739/TIP-Coalitions-Toolkit-2017-1-.pdf.
  27. 27.
    DiClemente, R. J., Crosby, R. A., & Kegler, M. C. (2002). Emerging Theories in Health Promotion Practice and Research. San Francisco: Jossey-Bass.Google Scholar
  28. 28.
    Guichon, J. R. M., I.; Buffler, P. ; Caplan, Art (2013). Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Preventive Medicine, 57(5), 409–413.CrossRefGoogle Scholar
  29. 29.
    Laurent-Ledru, V., Thomson, A., Monsonego, J. (2011). Civil society: A critical new advocate for vaccination in Europe. Vaccine, 29(4), 624–628.CrossRefGoogle Scholar
  30. 30.
    Frieden, T. R. (2014). Six components necessary for effective public health program implementation. American Journal of Public Health, 104(1), 17–22.CrossRefGoogle Scholar
  31. 31.
    Muraskin, W. (2004). The global alliance for vaccines and immunization: Is it a new model for effective public–private cooperation in international public health? American Journal of Public Health, 94(11), 1922–1925.CrossRefGoogle Scholar
  32. 32.
    North, A. L. N., & Linda, M. (2016). Human Papillomavirus vaccination requirements in US Schools: Recommendations for moving forward. American Journal of Public Health, 106(10), 1765–1770.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.CNR 7019, Hubert Department of Global Health, Rollins School of Public HealthEmory UniversityAtlantaUSA
  2. 2.Department of Public HealthGeorgia Comprehensive Cancer Control ProgramAtlantaUSA
  3. 3.Northwest Georgia Regional Cancer CoalitionRomeUSA
  4. 4.Georgia Cancer Control Consortium (GC3) HPV Work GroupAtlantaUSA
  5. 5.Department of Epidemiology, Rollins School of Public HealthEmory UniversityAtlantaUSA
  6. 6.Cancer Prevention and Control Program, Winship Cancer InstituteEmory UniversityAtlantaUSA
  7. 7.Emory Vaccine CenterEmory UniversityAtlantaUSA

Personalised recommendations